Related Articles |
Radiological and Scientific Comparability of Posterolateral Fusion and Transforaminal Interbody Fusion Strategies in Degenerative Lumbar Stenosis.
World Neurosurg. 2018 Jun 01;:
Authors: Bozkurt G, Isikay I, Hanalioglu S
Summary
OBJECTIVE: Fusion surgical procedure for lumbar degenerative stenosis is a longtime remedy mode. Regardless of comparable patient-related outcomes and radiological outcomes, the need of including interbody fusion to posterolateral fusion stays controversial. We aimed to check the scientific and radiological outcomes of posterolateral fusion and transforaminal interbody fusion strategies in degenerative lumbar stenosis with or with out spondylolisthesis.
METHODS: We retrospectively evaluated the scientific and radiological outcomes of 48 sufferers who had undergone decompression plus both posterolateral fusion (PLF, n = 23) or transforaminal interbody fusion (TLIF) plus PLF (TLIF + PLF, n = 25) procedures which integrated 71 segments for degenerative lumbar stenosis, with or with out spondylolisthesis.
RESULTS: The median follow-up length for the PLF and TLIF teams have been 26 and 31 months, respectively. Each procedures considerably improved the Oswestry Incapacity Index (ODI) and visible analog scale (VAS) scores; nonetheless, the postoperative ODI and VAS scores have been unaffected by the process kind. Postoperative disc heights and % adjustments in disc heights didn’t change by operation kind; nonetheless, the % change within the foramen areas was considerably larger within the TLIF group. The addition of TLIF to the PLF process resulted in considerably longer working time and extra intraoperative blood loss. CSF fistula was the one main complication famous. The radiological fusion charges have been comparable between each examine teams.
CONCLUSIONS: Each PLF and TLIF+PLF procedures have been efficient in ameliorating the signs of degenerative lumbar stenosis and spondylolisthesis. Though some radiological parameters favor TLIF, they weren’t mirrored within the scientific outcomes.
PMID: 29864570 [PubMed – as supplied by publisher]